Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company), a clinical-stage pharmaceutical company with a broad ...

Hormones can influence ovarian cancer growth by stimulating cell proliferation, angiogenesis (formation of new blood vessels) ...

Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company ...

Perspective from Livia Dickson ChenPhD in Nutrition · 11 years of experience · BrazilBenefits Parsnip supports immune ...

Alchemab Therapeutics, an antibody discovery firm known for identifying natural antibodies in disease-resistant individuals, ...

In this millenium, we will be required to answer such questions as: Will it be possible to treat ischemic heart disease by stimulating myocardial angiogenesis, and will it be feasible to cure ...

On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor ...

In this report, we will discuss some of the AACR data relating to angiogenesis in light of previous results from clinical trials, attempting to outline what has been achieved so far and what are ...

Received FDA Fast Track Designation for the investigation of CTX-009 in combination with paclitaxel for the treatment of patients with metastatic ...

The use of investigational combination therapies to treat erectile dysfunction (ED) had mixed outcomes, according to results from two trials presented here. In the ...

XC001 is designed to transiently grow new blood vessels to restore blood flow in the heart. It contains alternative splicing of the three isoforms of VEGF-A, which sets it apart from past attempts at ...